Ziel der Studie: Better define the pro-inflammatory microenvironment inside ECD lesions.  To evaluate the possibility to interfere with the progression of ECD by means of specific inhibitors already available for human usage, in order to find new therapeutic options for the disease.
Projektleiter: Lorenzo Dagna, M.D., San Raffaele Scientific Institute, Milano, ITALY
Kontaktdaten: Phone: +39-02-26434683 email: orenzo.dagna@unisr.it
Gewünschte Einbeziehung des Patienten: Derzeit sind keine bekannt.